Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Ana Gleisner

Concepts (332)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatectomy
39
2025
212
5.340
 Why?
Liver Neoplasms
39
2025
636
5.290
 Why?
Carcinoma, Hepatocellular
24
2025
270
4.750
 Why?
Pancreatic Neoplasms
24
2024
879
4.190
 Why?
Adenocarcinoma
25
2024
893
3.640
 Why?
Sentinel Lymph Node
8
2022
42
2.830
 Why?
Laparoscopy
9
2024
447
2.550
 Why?
Melanoma
12
2022
730
2.510
 Why?
Skin Neoplasms
12
2022
829
2.410
 Why?
Pancreaticoduodenectomy
11
2024
158
2.250
 Why?
Cholangiocarcinoma
10
2025
77
2.180
 Why?
Bile Duct Neoplasms
10
2025
99
2.090
 Why?
Lymph Node Excision
11
2024
164
2.070
 Why?
Pancreatectomy
7
2024
242
1.890
 Why?
Neoplasm Recurrence, Local
16
2025
956
1.680
 Why?
Postoperative Complications
18
2025
2470
1.680
 Why?
Sentinel Lymph Node Biopsy
11
2023
108
1.550
 Why?
Minimally Invasive Surgical Procedures
6
2025
171
1.490
 Why?
Retrospective Studies
76
2025
14525
1.300
 Why?
Survival Rate
32
2025
1872
1.270
 Why?
Tumor Burden
11
2025
286
1.210
 Why?
Aged
73
2025
22101
1.070
 Why?
Prognosis
36
2025
3772
1.060
 Why?
Databases, Factual
16
2025
1269
1.060
 Why?
Lymph Nodes
8
2024
471
0.970
 Why?
Liver Transplantation
11
2024
833
0.970
 Why?
Middle Aged
82
2025
31165
0.950
 Why?
Esophagectomy
4
2021
126
0.910
 Why?
Robotic Surgical Procedures
3
2019
113
0.860
 Why?
Esophageal Neoplasms
7
2023
297
0.850
 Why?
Lymphatic Metastasis
12
2025
320
0.840
 Why?
Conversion to Open Surgery
2
2020
15
0.830
 Why?
Breast Neoplasms
5
2024
2104
0.830
 Why?
Thrombelastography
1
2024
150
0.830
 Why?
Nomograms
2
2022
47
0.810
 Why?
Colorectal Neoplasms
9
2025
748
0.780
 Why?
Carcinoma, Pancreatic Ductal
5
2023
269
0.770
 Why?
Risk Assessment
16
2025
3260
0.740
 Why?
Humans
123
2025
129687
0.740
 Why?
Bilirubin
4
2025
96
0.740
 Why?
Rectal Neoplasms
5
2023
134
0.730
 Why?
Female
93
2025
68751
0.730
 Why?
Male
89
2025
63691
0.700
 Why?
Colonic Neoplasms
3
2024
241
0.610
 Why?
Serum Albumin
5
2025
149
0.600
 Why?
alpha-Fetoproteins
4
2025
42
0.570
 Why?
Quality of Life
2
2019
2694
0.570
 Why?
Neoplasm Staging
11
2025
1281
0.550
 Why?
Head and Neck Neoplasms
6
2019
544
0.550
 Why?
Follow-Up Studies
18
2025
4892
0.550
 Why?
Metastasectomy
3
2024
19
0.530
 Why?
Treatment Outcome
26
2025
10221
0.520
 Why?
Neoadjuvant Therapy
11
2023
379
0.510
 Why?
Peritoneal Neoplasms
3
2024
86
0.510
 Why?
Colectomy
3
2013
93
0.490
 Why?
Machine Learning
3
2025
441
0.490
 Why?
Liver Failure
3
2009
91
0.450
 Why?
Stomach Neoplasms
2
2024
97
0.420
 Why?
Axilla
3
2023
45
0.420
 Why?
Cytoreduction Surgical Procedures
3
2024
59
0.400
 Why?
Decision Making
1
2019
863
0.390
 Why?
Propensity Score
4
2024
265
0.380
 Why?
Aged, 80 and over
18
2024
7064
0.370
 Why?
Ampulla of Vater
2
2024
39
0.360
 Why?
Decision Support Techniques
2
2025
398
0.350
 Why?
Predictive Value of Tests
6
2025
1950
0.350
 Why?
Length of Stay
6
2025
1127
0.340
 Why?
ROC Curve
5
2025
503
0.340
 Why?
Neuroendocrine Tumors
2
2023
99
0.310
 Why?
Benchmarking
2
2021
176
0.310
 Why?
Adult
36
2025
35607
0.310
 Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
10
0.310
 Why?
Gallbladder Neoplasms
2
2024
21
0.300
 Why?
Margins of Excision
4
2023
38
0.290
 Why?
Risk Factors
14
2025
9787
0.280
 Why?
CA-19-9 Antigen
2
2024
22
0.280
 Why?
Mastectomy, Segmental
2
2017
86
0.270
 Why?
Disease-Free Survival
8
2024
646
0.270
 Why?
Liver Cirrhosis
4
2025
281
0.260
 Why?
Catheter Ablation
2
2008
336
0.250
 Why?
Survival Analysis
7
2024
1270
0.250
 Why?
Hyperglycemia
2
2020
327
0.240
 Why?
Infusions, Intra-Arterial
1
2025
53
0.240
 Why?
Time Factors
8
2025
6545
0.240
 Why?
United States
16
2024
13906
0.230
 Why?
gamma-Glutamyltransferase
1
2025
42
0.230
 Why?
Hepatic Artery
1
2025
59
0.230
 Why?
Medical Futility
1
2025
23
0.230
 Why?
Anastomotic Leak
1
2024
39
0.230
 Why?
Abdomen, Acute
1
2004
18
0.220
 Why?
Blood Loss, Surgical
1
2025
93
0.220
 Why?
Quality Indicators, Health Care
2
2025
298
0.220
 Why?
Cohort Studies
10
2023
5434
0.220
 Why?
Preoperative Care
3
2024
336
0.220
 Why?
Bacterial Infections
3
2006
233
0.220
 Why?
End Stage Liver Disease
1
2025
79
0.220
 Why?
Proportional Hazards Models
4
2025
1199
0.220
 Why?
Chemotherapy, Adjuvant
6
2025
377
0.210
 Why?
Lymphopenia
1
2024
60
0.210
 Why?
Combined Modality Therapy
6
2024
1201
0.210
 Why?
Odds Ratio
4
2019
1021
0.210
 Why?
Practice Guidelines as Topic
2
2024
1506
0.210
 Why?
SEER Program
2
2014
202
0.200
 Why?
Time-to-Treatment
1
2024
179
0.200
 Why?
Multilocus Sequence Typing
1
2022
13
0.200
 Why?
Lymphoscintigraphy
2
2019
9
0.200
 Why?
Lung Neoplasms
3
2023
2343
0.200
 Why?
Surgical Oncology
1
2022
22
0.200
 Why?
Sunburn
1
2002
26
0.200
 Why?
Sunscreening Agents
1
2002
23
0.200
 Why?
Mastectomy
1
2023
132
0.200
 Why?
Nevus, Pigmented
1
2002
32
0.190
 Why?
Pelvic Exenteration
2
2019
11
0.190
 Why?
Klatskin Tumor
1
2021
14
0.190
 Why?
Anesthetics, Inhalation
1
2021
28
0.180
 Why?
Artificial Intelligence
1
2024
245
0.180
 Why?
Chemoradiotherapy
4
2023
208
0.170
 Why?
Propofol
1
2021
62
0.170
 Why?
Prospective Studies
8
2022
7145
0.170
 Why?
Organ Preservation
4
2023
94
0.170
 Why?
Hyperthermia, Induced
2
2020
108
0.170
 Why?
Registries
2
2021
1896
0.160
 Why?
Reoperation
3
2017
541
0.160
 Why?
Scalp
1
2019
34
0.160
 Why?
Kaplan-Meier Estimate
3
2025
851
0.160
 Why?
Anesthesia
1
2021
135
0.160
 Why?
Regression Analysis
2
2019
997
0.160
 Why?
Inflammation
3
2024
2748
0.160
 Why?
Neutrophils
1
2024
1209
0.150
 Why?
Pancreatic Diseases
1
2019
71
0.150
 Why?
Skin Pigmentation
1
2019
45
0.150
 Why?
Referral and Consultation
1
2024
735
0.150
 Why?
Tomography, X-Ray Computed
3
2025
2510
0.150
 Why?
Patient Acceptance of Health Care
1
2024
763
0.140
 Why?
Population Surveillance
1
2021
439
0.140
 Why?
Appendiceal Neoplasms
1
2017
26
0.140
 Why?
Neoplasms
2
2022
2454
0.140
 Why?
Common Bile Duct Neoplasms
1
2017
27
0.140
 Why?
Patient Compliance
1
2021
568
0.140
 Why?
Disease Management
1
2021
588
0.130
 Why?
Gastric Outlet Obstruction
1
2017
9
0.130
 Why?
Pylorus
1
2017
17
0.130
 Why?
Waiting Lists
2
2009
238
0.130
 Why?
Carcinoma, Ductal, Breast
1
2017
80
0.130
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1560
0.130
 Why?
Radiotherapy, Intensity-Modulated
1
2018
129
0.130
 Why?
Hospitals, High-Volume
1
2016
39
0.130
 Why?
Cancer Care Facilities
1
2016
32
0.130
 Why?
Nutritional Status
1
2019
328
0.130
 Why?
Neuromuscular Agents
1
2017
31
0.130
 Why?
Botulinum Toxins, Type A
1
2017
41
0.130
 Why?
Genital Neoplasms, Female
1
2017
82
0.130
 Why?
Hospitals
1
2021
646
0.130
 Why?
Patient Reported Outcome Measures
1
2019
374
0.130
 Why?
Cannabis
1
2023
462
0.120
 Why?
Tomography, Emission-Computed, Single-Photon
1
2016
77
0.120
 Why?
Adenoma
1
2017
213
0.120
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
1049
0.120
 Why?
Radiosurgery
1
2018
321
0.120
 Why?
Antineoplastic Agents
3
2021
2044
0.110
 Why?
Phenotype
1
2002
3062
0.110
 Why?
Anti-Bacterial Agents
1
2004
1708
0.110
 Why?
Patient Readmission
1
2019
668
0.110
 Why?
Delivery of Health Care
1
2021
900
0.110
 Why?
Hospital Mortality
4
2024
851
0.110
 Why?
Morbidity
4
2021
302
0.110
 Why?
Unnecessary Procedures
1
2014
48
0.110
 Why?
Trauma Centers
2
2014
402
0.110
 Why?
Abdomen
1
2013
118
0.100
 Why?
Radiation Dosage
1
2014
154
0.100
 Why?
Clinical Competence
1
2019
1018
0.100
 Why?
Renal Insufficiency
1
2013
149
0.090
 Why?
Severity of Illness Index
3
2025
2739
0.090
 Why?
Asia
2
2021
58
0.090
 Why?
Triage
1
2012
207
0.090
 Why?
Carcinoma, Renal Cell
1
2012
178
0.080
 Why?
Age Factors
4
2022
3153
0.080
 Why?
Europe
2
2021
363
0.080
 Why?
Logistic Models
2
2025
1988
0.080
 Why?
Kidney Transplantation
2
2013
670
0.080
 Why?
Organ Preservation Solutions
2
2006
45
0.080
 Why?
Brain Injuries
1
2014
466
0.080
 Why?
Graft Survival
2
2009
514
0.080
 Why?
Practice Patterns, Physicians'
1
2017
1271
0.080
 Why?
Diagnostic Tests, Routine
2
2024
104
0.080
 Why?
Laparotomy
1
2008
106
0.070
 Why?
Bile Ducts, Extrahepatic
1
2008
22
0.070
 Why?
Kidney Neoplasms
1
2012
347
0.070
 Why?
Biliary Tract Surgical Procedures
1
2008
25
0.070
 Why?
Case-Control Studies
2
2007
3381
0.070
 Why?
Neoplasm Invasiveness
3
2020
483
0.070
 Why?
Intraoperative Care
1
2007
46
0.070
 Why?
Young Adult
7
2022
12457
0.070
 Why?
Cholangitis, Sclerosing
1
2008
71
0.070
 Why?
Electrocoagulation
1
2007
38
0.070
 Why?
Anus Neoplasms
1
2007
30
0.070
 Why?
Guideline Adherence
2
2024
527
0.070
 Why?
Congenital Hypothyroidism
1
1986
11
0.070
 Why?
Brazil
2
2008
154
0.070
 Why?
Multivariate Analysis
2
2025
1500
0.070
 Why?
Ultrasonography, Interventional
1
2007
128
0.060
 Why?
Fluorouracil
2
2022
197
0.060
 Why?
Wounds and Injuries
1
2012
711
0.060
 Why?
Mycophenolic Acid
1
2006
110
0.060
 Why?
Pandemics
2
2023
1496
0.060
 Why?
Adolescent
9
2022
20415
0.060
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
26
0.060
 Why?
Serum Albumin, Human
1
2024
6
0.060
 Why?
Platelet Count
1
2024
82
0.060
 Why?
Sample Size
1
2025
116
0.060
 Why?
Lymphocyte Count
1
2024
148
0.060
 Why?
Radiotherapy, Adjuvant
2
2019
208
0.050
 Why?
Zygomycosis
1
2003
6
0.050
 Why?
Gastrectomy
1
2024
102
0.050
 Why?
Bile Ducts, Intrahepatic
1
2024
65
0.050
 Why?
Developmental Disabilities
1
1986
254
0.050
 Why?
Cluster Analysis
1
2025
482
0.050
 Why?
Comorbidity
2
2022
1551
0.050
 Why?
Antibiotic Prophylaxis
1
2004
101
0.050
 Why?
Hepatocytes
1
2004
215
0.050
 Why?
Appendicitis
1
2004
125
0.050
 Why?
Lymphocytes
1
2024
377
0.050
 Why?
Biology
1
2023
85
0.050
 Why?
Capecitabine
1
2022
45
0.050
 Why?
Pneumonectomy
1
2023
151
0.050
 Why?
Carcinoma, Squamous Cell
1
2007
627
0.050
 Why?
Anesthesia, Intravenous
1
2021
15
0.050
 Why?
Anesthetics, Intravenous
1
2021
45
0.040
 Why?
Surgical Wound Infection
1
2004
282
0.040
 Why?
Esophagogastric Junction
1
2021
50
0.040
 Why?
Models, Biological
1
2008
1724
0.040
 Why?
Induction Chemotherapy
1
2021
70
0.040
 Why?
Body Mass Index
2
2024
2274
0.040
 Why?
Liver
2
2006
1839
0.040
 Why?
Thoracoscopy
1
2020
52
0.040
 Why?
Medical Oncology
1
2022
268
0.040
 Why?
Societies, Medical
1
2024
744
0.040
 Why?
Image-Guided Biopsy
1
2019
37
0.040
 Why?
Adenocarcinoma, Mucinous
1
2020
73
0.040
 Why?
Preoperative Period
1
2019
115
0.040
 Why?
Biomarkers, Tumor
1
2024
1161
0.040
 Why?
Perioperative Period
1
2017
49
0.030
 Why?
Oxidative Stress
1
2004
1264
0.030
 Why?
Carcinoma, Lobular
1
2017
47
0.030
 Why?
Occipital Bone
1
2017
18
0.030
 Why?
Operative Time
1
2017
124
0.030
 Why?
Parotid Gland
1
2017
22
0.030
 Why?
Obesity
1
2010
2885
0.030
 Why?
Gastric Emptying
1
2017
39
0.030
 Why?
Health Behavior
1
2002
743
0.030
 Why?
Longitudinal Studies
1
2024
2724
0.030
 Why?
Neck
1
2017
95
0.030
 Why?
Perioperative Care
1
2018
150
0.030
 Why?
Sex Factors
1
2022
1973
0.030
 Why?
Raffinose
2
2006
23
0.030
 Why?
Allopurinol
2
2006
62
0.030
 Why?
Glucose
1
2020
1003
0.030
 Why?
Consensus
1
2017
617
0.030
 Why?
Adenosine
2
2006
227
0.030
 Why?
Drug Administration Schedule
1
2015
766
0.030
 Why?
Glutathione
2
2006
349
0.030
 Why?
Cross-Sectional Studies
2
2022
5083
0.030
 Why?
Glasgow Coma Scale
1
2014
165
0.030
 Why?
Magnetic Resonance Imaging
1
2025
3394
0.030
 Why?
Radiation Injuries
1
2014
135
0.030
 Why?
Incidence
1
2019
2644
0.020
 Why?
Vital Signs
1
2012
41
0.020
 Why?
New South Wales
1
2012
14
0.020
 Why?
Child
6
2014
20882
0.020
 Why?
Disease Progression
1
2020
2628
0.020
 Why?
Baltimore
1
2012
45
0.020
 Why?
Italy
1
2012
99
0.020
 Why?
Child, Preschool
4
2014
10487
0.020
 Why?
Hospital Costs
1
2012
115
0.020
 Why?
Pharmaceutical Preparations
1
2013
171
0.020
 Why?
Biological Therapy
1
2011
28
0.020
 Why?
Albuminuria
1
1992
183
0.020
 Why?
Chi-Square Distribution
1
2012
515
0.020
 Why?
Injury Severity Score
1
2012
509
0.020
 Why?
Lung
1
2023
3937
0.020
 Why?
Surveys and Questionnaires
1
2022
5427
0.020
 Why?
Glomerular Filtration Rate
1
2013
711
0.020
 Why?
Infant, Newborn
2
2014
5759
0.020
 Why?
Carcinoembryonic Antigen
1
2008
39
0.020
 Why?
Immunosuppressive Agents
1
2013
858
0.020
 Why?
Antimetabolites, Antineoplastic
1
2008
91
0.020
 Why?
Infant
3
2014
8987
0.020
 Why?
Radiopharmaceuticals
1
2008
168
0.020
 Why?
Sensitivity and Specificity
1
2012
1844
0.020
 Why?
Fluorodeoxyglucose F18
1
2008
128
0.020
 Why?
Colorado
1
2017
4405
0.020
 Why?
Retreatment
1
2007
70
0.020
 Why?
Cholecystectomy
1
2007
58
0.020
 Why?
Positron-Emission Tomography
1
2008
282
0.020
 Why?
Incidental Findings
1
2007
80
0.020
 Why?
Neoplasm, Residual
1
2007
121
0.020
 Why?
Biopsy, Needle
1
2007
187
0.020
 Why?
Tablets, Enteric-Coated
1
2006
6
0.020
 Why?
Hepatitis B
1
2007
66
0.020
 Why?
Histidine
1
2006
60
0.020
 Why?
Radiography
1
2008
797
0.020
 Why?
Psychological Tests
1
1986
135
0.020
 Why?
Overweight
1
2010
531
0.020
 Why?
Graft Rejection
1
2009
598
0.010
 Why?
Tryptophan
1
2006
177
0.010
 Why?
Insulin
2
2006
2329
0.010
 Why?
Glutathione Disulfide
1
2004
32
0.010
 Why?
Hepatitis C
1
2007
244
0.010
 Why?
Sulfamethoxypyridazine
1
1983
1
0.010
 Why?
Trimethoprim
1
1983
7
0.010
 Why?
Gastrointestinal Diseases
1
2006
198
0.010
 Why?
Liver Function Tests
1
2004
112
0.010
 Why?
Anti-Infective Agents, Urinary
1
1983
13
0.010
 Why?
Amphotericin B
1
2003
30
0.010
 Why?
Liver Diseases
1
2006
291
0.010
 Why?
Patient Selection
1
2007
660
0.010
 Why?
Antifungal Agents
1
2003
130
0.010
 Why?
Cause of Death
1
2004
395
0.010
 Why?
Immunocompromised Host
1
2003
199
0.010
 Why?
Urinary Tract Infections
1
1983
151
0.010
 Why?
Reperfusion Injury
1
2004
272
0.010
 Why?
Cardiovascular Diseases
1
1992
2008
0.010
 Why?
Diabetes Mellitus, Type 1
1
1992
3629
0.010
 Why?
Cholesterol
1
1992
412
0.010
 Why?
Blood Pressure
1
1992
1736
0.000
 Why?
Sulfamethoxazole
1
1983
7
0.000
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1983
38
0.000
 Why?
Escherichia coli Infections
1
1983
108
0.000
 Why?
Drug Combinations
1
1983
331
0.000
 Why?
Microbial Sensitivity Tests
1
1983
349
0.000
 Why?
Escherichia coli
1
1983
766
0.000
 Why?
Clinical Trials as Topic
1
1983
1005
0.000
 Why?
Gleisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (332) concept(s)
_
Co-Authors Expand Description
See all (42) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)